[EN] COVALENT RAS INHIBITORS AND USES THEREOF<br/>[FR] INHIBITEURS DE RAS COVALENTS ET LEURS UTILISATIONS
申请人:REVOLUTION MEDICINES INC
公开号:WO2021108683A1
公开(公告)日:2021-06-03
The disclosure features compounds, or pharmaceutically acceptable salts thereof, alone and in combination with other therapeutic agents, pharmaceutical compositions, and protein conjugates thereof, capable of modulating biological processes including Ras, and their uses in the treatment of cancers.
Reaction of carbodiimides with α-Br(Cl)-aryl acetic acids produces N,N′-substituted 5-arylhydantoins under very mild conditions and high yields. When the carbodiimides are generated in situ by Staudinger reaction, the process becomes a one-pot, three-component sequential synthesis of libraries of differently substituted 5-arylhydantoins.
ULRICH, HENRI;RICHTER, REINHARD;TUCKER, BENJAMIN, J. HETEROCYCL. CHEM., 24,(1987) N 4, 1121-1123
作者:ULRICH, HENRI、RICHTER, REINHARD、TUCKER, BENJAMIN
DOI:——
日期:——
Selective formation of formamidines, carbodiimides and formimidates from isocyanide complexes of Mn(<scp>i</scp>) mediated by Ag<sub>2</sub>O
作者:Javier Ruiz、Daniel Sol、María A. Mateo、Marilín Vivanco
DOI:10.1039/c8dt01200h
日期:——
The isocyanide ligands in complexes fac-[Mn(CNR)(bipy)(CO)3]+ are selectively transformed into formamidines, carbodiimides and formimidates upon nucleophilic addition of NH2Me or alkoxides and subsequent treatment with Ag2O, which promotes tautomerization or oxidation processes of the former carbene ligands.